- Original article
- Open access
- Published:
Evaluating the role of the hepatitis C virus in the pathogenesis of Hodgkin’s lymphoma in Egyptian patients
The Egyptian Journal of Internal Medicine volume 24, pages 43–46 (2012)
Abstract
Background
Hepatitis C is an infection caused by a virus that attacks the liver and leads to inflammation. Several studies from Europe have reported a high prevalence of hepatitis C virus (HCV) infection in patients with non-Hodgkin’s lymphoma. It has been suggested that HCV plays a role in the pathogenesis of B-cell non-Hodgkin’s lymphoma (B-NHL). The aim of our study was to determine the prevalence of HCV infection in patients with B-NHL in the Egyptian population and to compare it with apparently healthy volunteers (as a control group).
Patients and methods
The current study was carried out on 50 patients diagnosed with B-NHL (as a patient group) as well as 35 healthy individuals (as a control group). HCV status was evaluated by the detection of anti-HCV antibodies using the enzyme-linked immunosorbent assay (ELISA) technique as well as the detection of HCV RNA by a reverse transcription PCR (RT-PCR).
Results
In terms of the results of anti-HCV antibodies by ELISA, 26 of 50 patients (52%) were positive in patients with B-NHL compared with 10 of 35 cases (28.6%) in the control group (P =0.0541). HCV RNA detection by RT-PCR was positive in 30 of 50 patients (60%) with B-cell lymphoma compared with 15 of 35 patients (42.9%) in the control group (P = 0.1823).
Conclusion
In conclusion, the results of our study show that there is a higher incidence of HCV infection in B-NHL patients compared with apparently healthy individuals. This supports the suspected role of HCV in the pathogenesis and etiology of B-NHL.
References
Lemon SM, Walker C, Alter MJ, et al. Fields virology:hepatitis C virus. Philadelphia, PA, USA:Lippincott Williams & Wilkins; 2007. pp. 1253–1304.
Choo QL, Kuo G, Weiner AJ, et al. Isolation of CDNA clone derived from a blood borne non A, non B viral hepatitis genome. Science 1989; 244:359–362.
Pawlotsky JM. Pathology of hepatitis C virus infections and related liver diseases. Trends Microbiol 2004; 12:96–102.
Ferri C, Greco F, Longombardo G, et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol 1991; 9:621–624.
Zuckerman E. Expansion of CD5 B-cell overexpressing CD81 in HCV infection:towards better understanding the link between HCV infection, B-cell activation and lymphoproliferation. J Hepatol 2003; 38:674–676.
Ohsawa M, Shingu N, Miwa H, et al. Risk of non-Hodgkin’s lymphoma in patients with hepatitis C virus infection. Int J Cancer 1999; 80:237–239.
Monti G, Pioltelli P, Saccardo F, et al. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. Arch Intern Med 2005; 165:101–105.
Pioltelli P, Zehender G, Monti G, et al. HCV and non-Hodgkin lymphoma. Lancet 1996; 347:624–625.
Silvestri F, Baccarani M. Hepatitis C virus-related lymphomas. Br J Haematol 1997; 99:475–480.
Viswanatha DS, Dogan A. Hepatitis C virus and lymphoma. J Clin Pathol 2007; 60:1378–1383.
Sansonno D, Carbone A, De Re V, et al. Hepatitis C Virus infection:cryo-globulinemia, and beyond. Rheumatology (Oxford) 2007; 46:572–578.
Isaacson PG. Update on MALT lymphomas. Best Pract Res Clin Haematol 2005; 18:57–68.
Ferreri AJ, Ernberg I, Copie-Bergman C. Infectious agents and lymphoma development:molecular and clinical aspects. J Intern Med 2009; 265:421–438.
Nieters A, Kallinowski B, Brennan P, et al. Hepatitis C and risk of lymphoma:results of the European multicenter case-control study EPILYMPH. Gastro-enterology 2006; 131:1879–1886.
Hermine O, Lefrère F, Bronowicki JP, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002; 347:89–94.
Vallisa D, Bernuzzi P, Arcaini L, et al. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin’s lymphoma:a multicenter Italian experience. J Clin Oncol 2005; 23:468–473.
Besson C, Canioni D, Lepage E, et al. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d’Etude des Lymphomes de l’Adulte programs. J Clin Oncol 2006; 24:953–960.
Visco C, Arcaini L, Brusamolino E, et al. Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma:analysis of 156 patients from northern Italy. Ann Oncol 2006; 17:1434–1440.
Cacoub P, Poynard T, Ghillani P, et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment virus C. Arthritis Rheum 1999; 42:2204–2212.
Zignego AL, Brechot C. Extrahepatic manifestations of HCV infection:facts and controversies. J Hepatol 1999; 31:369–376.
Zignego AL, Ferri C, Pileri SA, et al. Extrahepatic manifestations of hepatitis C virus infection:a general overview and guidelines for a clinical approach. Dig Liver Dis 2007; 39:2–17.
Zuckerman E, Zuckerman T, Levine AM, et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997; 127:423–428.
Franzin F, Efremov DG, Pozzato G, et al. Clonal B-cell expansions in peripheral blood of HCV-infected patients. Br J Haematol 1995; 90:548–552.
Ellis M, Rathaus M, Amiel A, et al. Monoclonal lymphocyte proliferation and bcl-2 rearrangement in essential mixed cryoglobulinemia. Eur J Clin Invest 1995; 25:833–837.
Ferri C, Caracciolo F, Zignego AL. Hepatitis C virus infection in patients with non-Hodgkin’s lymphoma. Br J Haematol 1994; 88:392–394.
Pozzato G, Mazzaro C, Crovatto M, et al. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 1994; 84:3047–3053.
Brind AM, Watson JP, Kestervan P, et al. Non-Hodgkin’s lymphoma and hepatitis C virus infection. Leuk Lymphoma 1996; 21 (1–2):127–130.
Tomita N, Kodama F, Takabayashi M, et al. Clinical features and outcome in HCV-positive aggressive non-Hodgkin’ lymphoma. Leuk Lymphoma 2003; 44:1159–1164.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Nasr, A.S., Tawfik, N.M., Aziz, E.M.A. et al. Evaluating the role of the hepatitis C virus in the pathogenesis of Hodgkin’s lymphoma in Egyptian patients. Egypt J Intern Med 24, 43–46 (2012). https://doi.org/10.7123/01.EJIM.0000419546.28308.26
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.7123/01.EJIM.0000419546.28308.26